PRELIMINARY-RESULTS OF A RANDOMIZED PHASE-III TRIAL OF AN ESTABLISHEDCHEMOTHERAPY (CT) REGIMEN WITH OR WITHOUT LENOGRASTIM (RHUG-CSF) IN SMALL-CELL LUNG-CANCER (SCLC) - IMPACT ON SURVIVAL
U. Gatzemeier et al., PRELIMINARY-RESULTS OF A RANDOMIZED PHASE-III TRIAL OF AN ESTABLISHEDCHEMOTHERAPY (CT) REGIMEN WITH OR WITHOUT LENOGRASTIM (RHUG-CSF) IN SMALL-CELL LUNG-CANCER (SCLC) - IMPACT ON SURVIVAL, European journal of cancer, 33, 1997, pp. 1033-1033